Press release
Chikungunya Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities
Chikungunya
What Is the Projected Growth of the Chikungunya Market?
In recent times, there has been robust growth in the chikungunya market size. It is projected to expand from $0.59 billion in 2024 to $0.65 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%. Factors that have contributed to this growth during the historic period include a rise in per capita spending on healthcare, an increase in the occurrence of emerging and re-emerging infectious diseases, growth in personal disposable income, changing climate conditions, and heightened awareness about mosquito-borne diseases.
Within the forthcoming years, the chikungunya market is projected to witness a robust expansion, anticipated to reach $0.93 billion by 2029 with a compound annual growth rate (CAGR) of 9.4%. The predicted growth in the foreseeable future is due to an increase in global clinical trials, an aging population, the escalating need for vaccination, rising initiatives by the government and non-governmental organizations, growing government investments, and favorable legislations. Key trends to look forward to in the forecasted period comprise progress in biotechnological approaches for the advancement of vaccines, the emergence of new vaccine prospects, the application of CRISPR and AI in fostering innovative solutions, strategic alliances among pharmaceutical entities, and the incorporation of telemedicine services.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21137
What Are the Different Chikungunya Market Segments?
The chikungunya market covered in this report is segmented -
1) By Type: Antiviral Drugs, Herbal And Complementary Treatments, Supportive Care, Vaccines
2) By Product Form: Liquid Form, Powder, Solid Form
3) By Disease Stage: Acute, Chronic, Post-Infection
4) By Sales Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Supermarkets
5) By End User: Caregivers, Healthcare Professionals, Patients
Subsegments:
1) By Antiviral Drugs: Nucleoside Analogues, Protease Inhibitors
2) By Herbal And Complementary Treatments: Ayurvedic Remedies, Homeopathic Treatments, Traditional Chinese Medicine
3) By Supportive Care: Pain Relievers (NSAIDs, Acetaminophen), Fluid Therapy, Physiotherapy
4) By Vaccines: Live-Attenuated Vaccines, Inactivated Vaccines, mRNA-Based Vaccines
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21137&type=smp
What Are the Primary Drivers Shaping the Chikungunya Market?
The escalation in instances of diseases carried by mosquitos is projected to spur the expansion of the chikungunya market. Diseases, such as chikungunya, dengue and zika virus, are passed on to humans via contaminated aedes mosquitoes, creating substantial public health issues across the globe. The increasing worldwide cases of diseases carried by mosquitos stem from factors such as climate change, urban growth, deforestation, accumulation of stagnant water, insufficient vector control procedures, heightened global travel, and resistance to insecticides. Treatments for chikungunya help those suffering from mosquito-borne diseases by alleviating symptoms like fever, joint pain, and inflammation, thus enhancing comfort and mobility, diminishing the danger of complications, and aiding recovery through hydration, pain control and supportive care. For example, the UK Health Security Agency, a government agency in the UK, reported in December 2024 that the number of dengue cases among vacationing travelers returning to England, Wales, and Northern Ireland climbed to 473 in the timeframe January to June 2024, a 201% jump as compared to the 157 cases noted during that same timeframe in 2023. Hence, the escalating global cases of diseases carried by mosquitos is fuelling the expansion of the chikungunya market.
Which Companies Are Leading in the Chikungunya Market?
Major companies operating in the chikungunya market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Quest Diagnostics Incorporated, Eurofins Scientific SE, Grifols Diagnostic Solutions Inc., bioMérieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Euroimmun AG, Evotec SE, Valneva SE, ELITechGroup S.A.S., Vaxart Inc., BioPerfectus Biotechnology Co. Ltd., CTK Biotech Inc., Creative Diagnostics Inc., Inovio Pharmaceuticals Inc., Biotrol Laboratories Pvt. Ltd.
What Trends Are Expected to Dominate the Chikungunya Market in the Next 5 Years?
Leading firms in the chikungunya market are prioritizing the creation of cutting-edge vaccines designed to boost immunity, mitigate disease outbreak, and manage the rising global health implications of chikungunya virus infections. One such vaccine is a live attenuated chikungunya vaccine. This vaccine uses a debilitated form of the chikungunya virus to provoke an immune response without inflicting the disease, creating long-lasting safeguarding. For example, in November 2023, Valneva SE, a biotechnology organization based in France, released IXCHIQ, a live attenuated chikungunya vaccine approved by the FDA, a US government agency. This approval was fast-tracked based on anti-CHIKV neutralizing antibody titers, with ongoing approval relying on the verification of clinical benefits in subsequent studies. The FDA gave Valneva a Priority Review Voucher (PRV), which the corporation plans to convert into funding for its research and development endeavors. IXCHIQ is administered in a one-time muscle injection and includes a weak, live version of the chikungunya virus, which could potentially elicit symptoms in patients similar to those caused by the chikungunya disease.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/chikungunya-global-market-report
What Are the Top Revenue-Generating Geographies in the Chikungunya Market?
North America was the largest region in the chikungunya market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chikungunya market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Chikungunya Market?
2. What is the CAGR expected in the Chikungunya Market?
3. What Are the Key Innovations Transforming the Chikungunya Industry?
4. Which Region Is Leading the Chikungunya Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chikungunya Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities here
News-ID: 4069556 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Chikungunya
Chikungunya Pipeline Insight 2025: 10+ Advancing Therapies and Key Companies in …
The therapeutic landscape for Chikungunya, a viral disease transmitted by mosquitoes that causes severe joint pain, fever, and rash, is rapidly evolving, fueled by advancements in antiviral research and vaccine development. Leading biopharmaceutical companies such as Valneva, Moderna Therapeutics, Themis Bioscience, FIT Biotech, Bharat Biotech, and Emergex Vaccines are at the forefront of developing innovative therapies, targeting various stages of the virus lifecycle, immune modulation, and pain management to alleviate…
Chikungunya Fever Global Clinical Trials Review, H2, 2018: Researchmoz.us
Researchmoz added Most up-to-date research on "Chikungunya Fever Global Clinical Trials Review, H2, 2018" to its huge collection of research reports. An insight on the important factors and trends influencing the market.
Latest clinical trial report, Chikungunya Fever Global Clinical Trials Review, H2, 2018" provides an overview of Chikungunya Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Chikungunya Fever. Report includes an overview…
Chikungunya Fever Market Segmentation 2018 with Recent Trend by 2023
Chikungunya Fever Market - Highlights
Chikungunya fever is a mosquito borne disease. The caU.S.Ative agent is a RNA virus that belongs to the alphavirus genus of the family Togaviridae. The transmission of the disease occurs from human to human by the bites of infected female mosquitoes. Most commonly, the mosquitoes involved are Aedes aegypti and Aedes albopictus. The symptoms of the disease includes muscle pain, headache, nausea, fatigue and rash.
There is…
Chikungunya Fever Market Worldwide Segmentation with Top Key Merchant – Avail …
Chikungunya Fever Market - Highlights
Chikungunya fever is a mosquito borne disease. The caU.S.Ative agent is a RNA virus that belongs to the alphavirus genus of the family Togaviridae. The transmission of the disease occurs from human to human by the bites of infected female mosquitoes. Most commonly, the mosquitoes involved are Aedes aegypti and Aedes albopictus. The symptoms of the disease includes muscle pain, headache, nausea, fatigue and rash.
There is…
Chikungunya Fever Market Worldwide Segmentation with Top Key Merchant – Avail …
The Worldwide Chikungunya Fever Market Research Reports Avail to Market Research Future. The Report Provides Detail Information about and Strategies used by Top Key Players in the Industry.
Chikungunya Fever Market - Highlights
Chikungunya fever is a mosquito borne disease. The caU.S.Ative agent is a RNA virus that belongs to the alphavirus genus of the family Togaviridae. The transmission of the disease occurs from human to human by the bites of infected…
Chikungunya Fever (Infectious Disease) Pipeline Forecast Report, H1, 2017 - Phar …
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chikungunya Fever Market- Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chikungunya Fever (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press…
